AA
Aftab Alam Khan
About Aftab Alam Khan
Data last updated:
Aftab Alam Khan has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Mark Biomedicals Private Limited and Markcode Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Mark Biomedicals Private Limited at ₹1.01 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mark Biomedicals Private Limited U85100TG2017PTC119263 | Director | 30 Sep 2017 | 2017 | ₹1.01 Cr (FY 2025) | Active |
| Markcode Private Limited U62013TS2024PTC183850 | Director | 28 Mar 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aftab Alam Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aftab Alam Khan
Aftab Alam Khan has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Mark Biomedicals Private Limited and Markcode Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Mark Biomedicals Private Limited at ₹1.01 Cr (FY 2025).
Aftab Alam Khan is associated with 2 companies as Director, including Mark Biomedicals Private Limited (₹1.01 Cr), Markcode Private Limited.
Aftab Alam Khan has expertise in General Business.
Aftab Alam Khan has 9 years in corporate governance.
By reported revenue, the largest current company of Aftab Alam Khan is Mark Biomedicals Private Limited, with revenue of ₹1.01 Cr (FY 2025).
Aftab Alam Khan currently holds positions at 2 companies: Mark Biomedicals Private Limited (₹1.01 Cr), Markcode Private Limited.